Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease
Herbert Nar(Boehringer Ingelheim (Germany)), Thomas Klein(Central Institute for Art History), Timothy C. Hardman, Oliver Hucke(Boehringer Ingelheim (Germany)), Gisela Schnapp(Boehringer Ingelheim (Germany))
Cited by 11
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383